Growing evidence strongly suggests that you can get bacterial vaginosis from the same partner, repeatedly. For years, BV was considered an imbalance of vaginal bacteria rather than a sexually transmitted condition, and many clinicians still frame it that way. But research over the past decade has upended that picture. Studies now show that BV-associated bacteria live on the penis and in the urethra, that sexual couples share nearly identical strains of these organisms, and that treating the male partner alongside the woman dramatically cuts recurrence. The reality is more layered than a simple yes or no, though, because sex with a partner is only one of several forces that can tip the vaginal microbiome toward BV.
The Penile Microbiome as a Hidden Reservoir
One of the most important discoveries in BV research has been that the penis harbors many of the same bacterial species found in BV. A study of heterosexual couples found that the penile skin and urethral bacteria of men whose female partners had BV were significantly more similar to their partner’s vaginal microbiome than to the vaginal microbiome of other women with BV. Specific BV-associated species were concordant between women with BV and their male partners, suggesting the bacteria are shared within couples rather than randomly acquired.1PubMed Central. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis Researchers have even been able to predict whether a woman would develop BV based on the bacterial composition of her male partner’s penile meatus, with key BV-associated organisms like Gardnerella vaginalis, Sneathia, and Prevotella ranking among the most predictive species.2PubMed Central. The Microbiome Composition of a Man’s Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy
A narrative review examining studies that simultaneously evaluated penile and vaginal microbiomes confirmed that specific bacterial taxa are highly correlated between partners, with evidence for transmission going in both directions.3PubMed Central. Role of the penile microbiome in female sex partner risk of bacterial vaginosis and sexually transmitted infections: a narrative review This means it is not just that women “give” bacteria to men during sex. Men can carry BV-associated bacteria and pass them back, creating a loop. The man himself typically has no symptoms, no discharge, no discomfort. He may have no idea he is carrying anything at all, which is part of why the reinfection cycle has been so hard to break.
When Researchers Actually Treated the Male Partner
If the penis is a reservoir, the logical question is whether treating the male partner would help. For decades, clinical trials of male partner treatment showed no benefit, but those trials used only oral antibiotics, which may not have reached the bacteria living on penile skin. A landmark randomized controlled trial published in the New England Journal of Medicine changed the approach: women received standard BV treatment, while their male partners received both oral antibiotics and a topical antibiotic cream applied to the penile skin for seven days. The results were striking. BV recurred in about a third of women in the partner-treatment group, compared with roughly two-thirds in the control group.4PubMed. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
An earlier open-label pilot study had hinted at this possibility. In that study, women at high risk for recurrence were treated alongside male partners who received the same combination of oral metronidazole and topical penile clindamycin. Only about one in six women recurred within twelve weeks, a far lower rate than typically seen.5PubMed Central. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis These findings together make a compelling case that for many women in steady heterosexual relationships, their partner is a meaningful part of the BV problem. Treating both people at the same time addresses the reinfection channel that standard treatment ignores.
This does not mean partner treatment is yet standard practice everywhere. Clinical guidelines have been slow to update, partly because the older, less effective partner-treatment trials muddied the water for years. If you are dealing with recurrent BV and your clinician has not raised the possibility of treating your partner, it is worth bringing up.
Why BV Keeps Coming Back After Treatment
Reinfection from a partner is one explanation for recurrence, but it is not the only one. BV-associated bacteria can form a tough, multi-species biofilm that coats the vaginal lining. This biofilm acts as a shield: antibiotics kill the free-floating bacteria but can struggle to penetrate the biofilm structure. Once treatment stops, the surviving bacteria within the biofilm re-emerge and repopulate the vagina.6PubMed Central. Fighting polymicrobial biofilms in bacterial vaginosis A comprehensive review of BV recurrence attributed the high failure rate of standard treatment to two overlapping mechanisms: persistence of BV bacteria or their biofilm after antibiotics, and reinfection from sexual partners.7PubMed Central. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment
This means that even if your partner is fully treated and no longer carrying BV-associated bacteria, recurrence can still happen because of what was already living in the biofilm. The two causes can also work together: antibiotics knock back the biofilm but do not eliminate it, and then reintroduction of the same bacteria from a partner gives the biofilm fresh fuel to bounce back. Breaking the cycle often requires addressing both fronts at once.
Transmission Between Female Partners
BV is not limited to heterosexual transmission. Research on women who have sex with women has consistently found high rates of concordance between partners. In one early study, monogamous female couples were examined for BV, and the likelihood of a partner having BV was roughly twenty times greater when the other partner had it.8PubMed. Bacterial vaginosis in lesbians: a sexually transmitted disease A larger study found a similar pattern: among women whose current female partner had also enrolled in the study, the vast majority of partners of women with BV also had BV, while partners of women without BV almost never had it.9PubMed Central. Prevalence and Risks for Bacterial Vaginosis in Women Who Have Sex With Women
Whole-genome sequencing has added molecular confirmation. A sexual-network study found that identical strains of BV-associated bacteria, including Gardnerella, Sneathia, and Prevotella species, were shared between female sexual contacts.10PubMed Central. Sexual transmission of urogenital bacteria: whole metagenome sequencing evidence from a sexual network study For women in same-sex relationships dealing with recurrent BV, the implication is the same as for heterosexual couples: treating only one partner while the other continues to carry the same organisms is unlikely to break the cycle.
How Semen and Condoms Factor In
Beyond carrying bacteria, semen itself can nudge vaginal conditions in a direction that favors BV. Semen is alkaline, with a pH well above the acidic range that healthy vaginal Lactobacillus bacteria prefer. A study measuring prostate-specific antigen as a biomarker for recent semen exposure found that women with detectable semen exposure were roughly two and a half times more likely to have BV after adjusting for other risk factors.11PubMed Central. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women The pH shift is temporary, but repeated exposure without barrier protection provides a recurring opportunity for BV-associated bacteria to gain a foothold.
Consistent condom use appears to help, though the benefit depends on whether you already have BV. In women without BV at baseline, consistent condom use was associated with a roughly 40-45% reduction in the odds of developing it.12Epidemiology. Condom Use and its Association With Bacterial Vaginosis and Bacterial Vaginosis-Associated Vaginal Microflora But among women who already had BV, consistent condom use did not significantly change six-month prevalence, suggesting that condoms are better at preventing new BV than at resolving existing infections.13PubMed Central. Effect of consistent condom use on six-month prevalence of bacterial vaginosis varies by baseline BV status This makes sense given what we know about biofilms: once BV bacteria have established themselves, blocking incoming bacteria from a partner may not be enough on its own.
The Circumcision Connection
Male circumcision reduces the surface area of warm, moist skin under the foreskin where anaerobic bacteria thrive. A randomized trial in Uganda found that female partners of circumcised men had roughly 40% lower risk of any BV and about 60% lower risk of severe BV at one-year follow-up compared to partners of uncircumcised men.14PubMed Central. The effects of male circumcision on female partner’s genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda Separate analysis confirmed that circumcision decreases the load of BV-associated bacteria on the penis.15PubMed Central. Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
This does not mean circumcision eliminates the risk. A circumcised man can still carry BV-associated organisms. But the reduced bacterial load translates into lower odds that his partner will develop or re-develop BV. It is one piece of the puzzle, not a solution on its own, and obviously not a decision most couples will make for the purpose of managing vaginal infections.
Non-Sexual Factors That Stack the Odds
Partner transmission can explain a lot of recurrent BV, but it does not explain all of it. Vaginal douching is one of the strongest non-sexual risk factors. A longitudinal study using rigorous statistical methods found that regular douching raised BV risk by about 21% compared to not douching.16PubMed Central. A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis—A Marginal Structural Modeling Analysis Another study found the risk was highest for women who had douched within the past week, with roughly double the odds of BV. Douching for hygiene purposes and douching for symptom relief were both associated with increased risk.17PubMed. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina The irony is hard to miss: many women douche because they are worried about odor from BV, and the douching itself makes the problem worse.
Genetics also plays a role, though the research is still in early stages. Genome-wide studies have identified several genetic variants linked to BV susceptibility, particularly in genes involved in immune signaling and inflammation.18JCI Insight. Social, microbial, and immune factors linking bacterial vaginosis and infectious diseases One study found that specific gene variants in stress-related pathways interacted with smoking status to influence BV risk, with the same genetic variant having opposite effects depending on whether the woman smoked.19PubMed Central. Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes None of this is practically useful at the individual level yet, but it helps explain why two women with the same partner, same sexual frequency, and same hygiene practices can have completely different experiences with BV.
Hormonal Contraception and BV Risk
Hormonal contraception appears to provide modest protection against BV. A systematic review and meta-analysis found that women using any form of hormonal contraception had about a 20-30% lower risk of prevalent, incident, or recurrent BV compared to non-users.20PLoS ONE. Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis A longitudinal study found particularly strong effects for injectable and implant contraceptives, which were also associated with greater remission of existing BV.21Sexually Transmitted Diseases. Longitudinal Association Between Hormonal Contraceptives and Bacterial Vaginosis in Women of Reproductive Age
The mechanism probably relates to how hormones influence vaginal pH and Lactobacillus populations. Estrogen promotes the growth of the glycogen-producing cells that feed protective Lactobacillus, so higher, more stable hormone levels may create an environment that is harder for BV bacteria to colonize. If you are already using hormonal contraception for other reasons, this may be a secondary benefit worth knowing about. If you are choosing a contraceptive method and recurrent BV is a major problem in your life, it might factor into the conversation with your provider, though it is not a strong enough effect on its own to drive the decision.
Intrauterine devices (IUDs), by contrast, do not appear to increase BV risk. A longitudinal study found that IUD users were no more likely to acquire BV than women using combined oral contraceptives, the ring, or the patch.22PubMed Central. Risk of Bacterial Vaginosis in Users of the Intrauterine Device: A Longitudinal Study This is reassuring given that older clinical lore sometimes blamed IUDs for vaginal infections.
Suppressive Therapy for Persistent Recurrence
When BV keeps coming back despite standard treatment and even partner treatment, clinicians sometimes turn to suppressive maintenance therapy. One approach uses a vaginal metronidazole gel applied twice weekly after an initial treatment course. In a randomized trial, this suppressive regimen cut the recurrence rate roughly in half during the maintenance phase, with about a quarter of women on the gel experiencing recurrence compared to nearly 60% on placebo.23PubMed. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis A separate study found that maintenance metronidazole gel prevented symptomatic recurrence in roughly 70% of compliant patients at six months, with similar numbers holding at twelve months for those who made it that far.24PubMed Central. Recurrent Bacterial Vaginosis: An Unmet Therapeutic Challenge
The downside is that suppressive antibiotics can cause yeast infections, and the benefits tend to fade once the maintenance period ends. Researchers are exploring vaginal microbiome transplantation (VMT) as an alternative. The concept mirrors fecal transplants for gut infections: vaginal fluid from a healthy donor with a robust Lactobacillus-dominant microbiome is transferred to a woman with recurrent BV. An early case series treated five women with intractable BV and saw full long-term remission in four of them, lasting five to twenty-one months.25PubMed Central. Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential VMT remains experimental, without standardized donor screening protocols or large trial data. But for women who have exhausted every conventional option, it represents a genuinely different approach that targets the root microbiome imbalance rather than just killing bacteria and hoping the right ones grow back.
The Emotional Weight of Recurrent BV
Recurrent BV is not just a medical nuisance. A qualitative study of women living with frequent recurrences found that most reported moderate to severe impacts on their physical, emotional, sexual, and social lives. Embarrassment, self-consciousness, shame, and distress were the most commonly described feelings. Many women felt disgusted or dirty, and the condition took a real toll on their willingness to be sexually intimate.26PubMed Central. The Burden of Bacterial Vaginosis: Women’s Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis Interestingly, women in that study did not generally question their partner’s fidelity because of BV, which aligns with clinical messaging that BV is not a traditional sexually transmitted infection. But the emerging science on partner transmission does raise the question of whether that messaging has been underselling the partner connection.
If you are in a relationship and dealing with BV that keeps coming back, it can feel isolating and frustrating, especially when treatment after treatment fails. Understanding that your partner’s microbiome may be part of the equation is not about assigning blame. It reframes the problem as something the couple can address together rather than something the woman has to manage alone. The partner-treatment trial data suggests that framing is not just emotionally healthier but medically more effective.
When Recurring Symptoms Are Not Actually BV
One more thing worth knowing: not every episode of discharge, odor, or irritation is BV, even if earlier episodes were. Cytolytic vaginosis is a condition caused by an overgrowth of Lactobacillus bacteria, the very organisms normally considered protective. It produces symptoms that closely mimic both BV and yeast infections, including increased discharge, burning, and itching. Because it looks so similar to more common infections, it is frequently misdiagnosed and treated with antibiotics or antifungals that either do nothing or make it worse.27PubMed Central. Cytolytic vaginosis: A review Diagnosis requires microscopic examination showing abundant Lactobacillus and broken-down vaginal cells without the organisms that cause BV or yeast infections. The treatment is the opposite of BV treatment: baking soda sitz baths to raise vaginal pH, rather than antibiotics to kill bacteria.
If you have been diagnosed with BV multiple times but the standard treatments never seem to fully work, or if your symptoms have a cyclical pattern tied to the second half of your menstrual cycle when Lactobacillus growth peaks, it is worth asking your clinician about cytolytic vaginosis. Women can also swing between genuine BV and cytolytic vaginosis if aggressive treatment of one condition tips the balance too far in the other direction. A lab-confirmed diagnosis rather than empirical treatment based on symptoms alone is the best way to avoid chasing the wrong problem.